NCT06762262Active, not recruiting
Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients
Effects of Pilate Training Versus Moderate Intensity Continous Training on Dyspnea and Cardiovascular Fitness in Hypertensive Patients
Source: ClinicalTrials.gov · Last updated 7 Jan 2025
Brief summary (registry, in English)
Hypertension, commonly known as high blood pressure, continues to be the leading cause of both sickness and mortality globally. Generally, individuals in good health might have trouble breathing solely during vigorous exercise or when holding their breath, finding relief by stopping the activity or adjusting their breathing technique. Often patients with hypertension seek various treatments to relieve symptoms. The aim of this study is to compare the effects of Pilates Training and Moderate Intensity Continuous Training on dyspnea and cardiovascular fitness in hypertensive patients. The study would be randomized clinical trial. A total of thirty-four subjects will be assigned randomly by using block randomization into two groups. Group A will be given Pilates training while Group B will moderate intensity training. After confirmation of diagnosis with medical history and physical examination as well as chronic, mild-to moderate, and stable (\>1 year duration) hypertension (systolic blood pressure \[SBP\] between 140-179 mm Hg and diastolic blood pressure \[DBP\]between 90-109 mm Hg) recommended. 3-minute step test, VO2max and Modified BORG scale would be used as an outcome measure tools for cardiovascular parameters and dyspnea. The collected data will be analyzed in SPSS 25.0. Descriptive and inferential statistics will be applied after testing normality of data
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- First submitted
- 1 Jan 2025
- Start date
- 20 Apr 2024
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Riphah International University
- Diseases
- High blood pressure
- NCT number
- NCT06762262
What you commit to
- Study type: Interventional
- Planned participants: 52
- From 20 Apr 2024 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with Heart surgery
- Patients with presence of symptomatic congestive heart failure
- Smokers, alcoholic, diabetic, and other cardiac, renal, and respiratory disease patients (uncontrolled) would be excluded.
- Participants with no history of psychiatry or psychological disorders or abnormalities.
Other
- Patients with Permanent atrial fibrillation
- Patients with COPD
Who the study is looking for
- Participants must be between 45 to 70 years old
- Gender: Male and Female both
- Chronic, mild-to moderate, and stable (\>1 year duration) hypertension (systolic blood pressure
- \[SBP\] between 140-179 mm Hg and diastolic blood pressure \[DBP\] between 90-109 mm Hg).
- Single antihypertensive medication will be recruited.
- Participants have sedentary life style.
- Smokers, alcoholic, diabetic, and other cardiac problems (controlled) would be included.
Age in the registry: 45 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sheikh Zaid Hospital Coordinator of this site? Confirm its status | Quetta | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.